1. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry 
Massimo Martino, Francesco Lanza, Lorenzo Pavesi, Mustafa Öztürk, Didier Blaise, Rubén Leno Núñez, Harry C. Schouten, Alberto Bosi, Ugo De Giorgi, Daniele Generali, Giovanni Rosti, Andrea Necchi, Andrea Ravelli, Carmelo Bengala, Manuela Badoglio, Paolo Pedrazzoli, Marco Bregni 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages (March 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Kaplan-Meier curve of (A) DFS and (B) OS for the whole study population.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Kaplan-Meier estimates of OS in prespecified subset analyses by (A) age at surgery and (B) menopause status.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Kaplan-Meier estimates of OS in prespecified subset analyses by (A) tumor size and (B) tumor grading.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Kaplan-Meier estimates of median OS according to tumor HR status. 95% CI indicates 95% confidence interval.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

6. Figure 5
Kaplan-Meier estimates of median OS according to number of positive lymph nodes at surgery.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions